Mission : Our Strategic Aim
aims to be a leading development based company in cancer
Kancer Limited founders Dr New and
Mr Travers have been working in the fields of drug
delivery and discovery since 1980. Prior to Kancer's incorporation,
both of the founders (New and Travers) led drug delivery programs at
a leading biotechnology company between 1991 and 1998.
Two patents were acquired as
foundation technologies and a suite of patents have been developed
over the past 5 years which form the basis of the exclusive licences
owned by Kancer.